-+ 0.00%
-+ 0.00%
-+ 0.00%

Rigel Pharmaceuticals Q1 EPS $0.63 Beats $0.09 Estimate, Sales $53.30M Beat $43.87M Estimate

Benzinga·05/06/2025 20:31:16
Listen to the news
Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.09 by 600 percent. This is a 226 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $53.30 million which beat the analyst consensus estimate of $43.87 million by 21.50 percent. This is a 80.47 percent increase over sales of $29.53 million the same period last year.